Concepedia

Juvenile Myelomonocytic Leukemia

Maurizio Aricò, Andrea Biondi, Ching‐Hon Pui

Blood · 1997 · 207 citations · 87 references

Open access

Concepts

MedicineHematologyOncologyHematologic OncologyHematopathologyPediatric HematologyHematologic MalignanciesHematopoietic NeoplasmsLymphoid NeoplasmsLymphoid TumorsPediatric HematopathologyPediatric LeukemiasJuvenile Myelomonocytic LeukemiaLeukemia PathologyMyeloid NeoplasmsPathological SciencePediatric Bone Marrow Disorders

Abstract

this disease, emphasizing recent advances in its treatment and in understanding its pathological origin.

References

87

Tumour predisposition in mice heterozygous for a targeted mutation in Nf1

Tyler Jacks, T. Shane Shih, Earlene M. Schmitt et al. · Nature Genetics · 1994 · 777 citations

Life Sciences, Genetics, Molecular Genetics +11

Hematologic Remission and Cytogenetic Improvement Induced by Recombinant Human Interferon Alpha<sub>A</sub>in Chronic Myelogenous Leukemia

Moshe Talpaz, Hagop M. Kantarjian, Kenneth B. McCredie et al. · New England Journal of Medicine · 1986 · 660 citations

Medicine, Hematology, Immunology +15

Benzodiazepine Peptidomimetics: Potent Inhibitors of Ras Farnesylation In Animal Cells

Guy L. James, Joseph L. Goldstein, Michael S. Brown et al. · Science · 1993 · 629 citations

Medicine, Oncology, Pharmacology +15

Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells

Gideon Bollag, D. Wade Clapp, Shane Shih et al. · Nature Genetics · 1996 · 608 citations

Medicine, Hematology, Molecular Genetics +13

Selective Inhibition of <i>ras</i> -Dependent Transformation by a Farnesyltransferase Inhibitor

Nancy E. Kohl, Scott D. Mosser, S. J. DESOLMS et al. · Science · 1993 · 582 citations

Medicine, Oncology, Pharmacology +13